Arbutus Biopharma Corporation ABUS Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's net income?
- Arbutus Biopharma Corporation (ABUS) reported net income of $169.7M in Q1 2026.
- How has Arbutus Biopharma Corporation's net income changed year-over-year?
- Arbutus Biopharma Corporation's net income increased by 791.9% year-over-year, from -$24.53M to $169.7M.
- What is the long-term trend for Arbutus Biopharma Corporation's net income?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's net income has grown at a -18.6% compound annual growth rate (CAGR), from -$76.25M to -$33.5M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.